American International Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
AIM
NAMA
WP
American International Group's ARCT Position: Q2 2024 in Review
American International Group sold out of Arcturus Therapeutics (ARCT) in Q2 2024, closing a stake of 11,491 shares — an estimated $388K sold.
American International Group first reported a position in ARCT in Q4 2014 and held it in 19 quarters. The position peaked at $555K in Q4 2020. 171 funds tracked by Wall St. Rank hold ARCT as of Q2 2024.
- American International Group reported no remaining Arcturus Therapeutics position as of Q2 2024 after selling out during the quarter.
- American International Group sold 11,491 Arcturus Therapeutics shares in Q2 2024, an estimated $388K.
- American International Group first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 19 quarters.
- American International Group's Arcturus Therapeutics position peaked at $555K in Q4 2020.
- 171 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.